1. Home
  2. EDAP vs OKYO Comparison

EDAP vs OKYO Comparison

Compare EDAP & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$2.96

Market Cap

75.5M

Sector

Health Care

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$2.04

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDAP
OKYO
Founded
1979
2007
Country
France
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.5M
79.7M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
EDAP
OKYO
Price
$2.96
$2.04
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$8.50
$6.00
AVG Volume (30 Days)
68.3K
167.7K
Earning Date
11-06-2025
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$74,853,925.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.61
N/A
52 Week Low
$1.21
$0.90
52 Week High
$3.44
$3.35

Technical Indicators

Market Signals
Indicator
EDAP
OKYO
Relative Strength Index (RSI) 61.91 50.09
Support Level $2.58 $1.75
Resistance Level $3.44 $1.95
Average True Range (ATR) 0.28 0.20
MACD 0.05 0.01
Stochastic Oscillator 65.41 47.83

Price Performance

Historical Comparison
EDAP
OKYO

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: